Extended, high dose VEGF antagonist regimens for treatment of angiogenic eye disorders
MDE20260706A1Pending Publication Date: 2026-09-30REGENERON PHARMACEUTICALS INC +1
0 Cites 0 Cited by
Patent Information
- Application Number
- MDE20260706T
- Authority / Receiving Office
- MD · MD
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2022-05-16
- Publication Date
- 2026-09-30
Need to check novelty before this filing date? Find Prior Art
No text content released.